CLINICAL-APPLICATIONS OF POSITRON-EMISSION TOMOGRAPHY IN CANCER

[1] Boring CC, Squires TS, Tong T, Cancer Statistics, 1993, CA Cancer J Clin, 43, pp. 7-26, (1993)

[2] Warburg O, Wind F, Negleis E, On the metabolism of tumors in the body, The Metabolism of Tumours, pp. 254-270, (1930)

[3] Monakhov NK, Neistadt EL, Shavlovskil MM., Et al., Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues, J Natl Cancer Inst, 61, pp. 27-34, (1978)

[4] Hatanaka M, Transport of sugars in tumor cell membranes, Biochim Biophys Acta, 355, pp. 77-104, (1974)

[5] Zanzonico PB, Bigler RE, Leonard RW, Socks W, The enzymatic basis of the biodistribution of FDG: Implications for tumor imaging (abstr), J Nucl Med, 26, (1985)

[6] Weinhouse S, Changing perceptions of carbohydrate metabolism in tumors, Molecular Interrelations of Nutrition and Cancer, pp. 167-181, (1982)

[7] DiChiro G, DeLaPaz RL, Brooks RA., Et al., Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography, Neurology, 32, pp. 1323-1329, (1982)

[8] Okada J, Yoshikawa K, Itami M, Et al., Positron emission tomography using fluorine‐18‐fluorodeoxyglucose in malignant lymphoma: A comparison with proliferative activity, J Nucl Med, 33, pp. 325-329, (1992)

[9] Wahl RL, Hutchins GD, Buchsbaum DJ., Et al., Cancer, 67, pp. 1544-1550, (1991)

[10] Strauss LG, Conti PS, The applications of PET in clinical oncology, J Nucl Med, 32, pp. 623-648, (1991)

[1] Boring CC, Squires TS, Tong T, Cancer Statistics, 1993, CA Cancer J Clin, 43, pp. 7-26, (1993)

[2] Warburg O, Wind F, Negleis E, On the metabolism of tumors in the body, The Metabolism of Tumours, pp. 254-270, (1930)

[3] Monakhov NK, Neistadt EL, Shavlovskil MM., Et al., Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues, J Natl Cancer Inst, 61, pp. 27-34, (1978)

[4] Hatanaka M, Transport of sugars in tumor cell membranes, Biochim Biophys Acta, 355, pp. 77-104, (1974)

[5] Zanzonico PB, Bigler RE, Leonard RW, Socks W, The enzymatic basis of the biodistribution of FDG: Implications for tumor imaging (abstr), J Nucl Med, 26, (1985)

[6] Weinhouse S, Changing perceptions of carbohydrate metabolism in tumors, Molecular Interrelations of Nutrition and Cancer, pp. 167-181, (1982)

[7] DiChiro G, DeLaPaz RL, Brooks RA., Et al., Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography, Neurology, 32, pp. 1323-1329, (1982)

[8] Okada J, Yoshikawa K, Itami M, Et al., Positron emission tomography using fluorine‐18‐fluorodeoxyglucose in malignant lymphoma: A comparison with proliferative activity, J Nucl Med, 33, pp. 325-329, (1992)

[9] Wahl RL, Hutchins GD, Buchsbaum DJ., Et al., Cancer, 67, pp. 1544-1550, (1991)

[10] Strauss LG, Conti PS, The applications of PET in clinical oncology, J Nucl Med, 32, pp. 623-648, (1991)